Cerebrovascular disease in Italy and Europe: It is necessary to prevent a ‘pandemia’

European Journal of Cardiovascular Prevention & Rehabilitation

Volumn 9, Issue 3, 2002, Pages 143-145

  Gaddi, Antonio ^a,c   Cicero, Arrigo F G ^a   Poli, Andrea ^b   Nascetti, Simona ^a   Inzitari, Domenico ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Nutrition Foundation of Italy   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

cerebrovascular disease; epidemiology; hypercholesterolemia; risk factors; statins; stroke

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; PRAVASTATIN; SIMVASTATIN;

ALZHEIMER DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; EUROPE; HUMAN; ITALY; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; STROKE;

AGE DISTRIBUTION; ANTICHOLESTEREMIC AGENTS; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; EUROPE; HEALTH STATUS; HUMANS; HYPERCHOLESTEROLEMIA; ITALY; RISK FACTORS; SOCIAL CONDITIONS;

EID: 0036618821     PISSN: 17418267     EISSN: 17418275     Source Type: Journal    
DOI: 10.1177/174182670200900302     Document Type: Article

References (11)

1. Di Carlo A, Launer LJ, Breteler MM, Fratiglioni L, Lobo A, Martinez-Lage J, Schmidt R, Hofman A. Frequency of stroke in Europe: A collaborative study of population-based cohorts. ILSA Working Group and the Neurologic Diseases in the Elderly Research Group. Italian Longitudinal Study on Aging. Neurology 2000; 54 (suppl 5):S28–S33.
2. Jommi C, Cantu E, Anessi-Pessina E. New funding arrangements in the Italian National Health Service. Int J Health Plan Manage 2001; 16: 347–368.
3. Boden-Albala B, Sack RL. Lifestyle factors and stroke risk: Exercise, alcohol, diet, obesity, tuxedo, drug use, and stress. Curr Atheroscler Rep 2000; 2: 160–166.
4. Osseby GV, Manceau E, Lemesle-Martin M, Thomas V, Giroud M. Statins and stroke. Ann Endocrinol 2001; 62: 113–120.
5. Collins R. LIFE-SAVER: World's largest cholesterol lowering trial reveals massive benefits for high risk patients. http://www.ctsu.ox.ac.uk/hps/pr.shtml.
6. Inzitari D, Eliasziw M, Gates P, Sharpe BI, Chan RKT, Meldrum HE, Barnett HJM, For the North America Symptomatic Carotid Endoarteriectomy Trial Collaborators. The causes and risk of stroke in patients with asymptomatic internal-carotid-artery stenosis. N Engl J Med 2000; 342: 1693–1700.
7. Gil-Nunez AC, Villanueva JA. Advantages of lipid-lowering therapy in cerebral ischemia: Role of HMG-CoA reductase inhibitors. Cerebrovasc Dis 2001; 11 (Supplement 1):85–95.
8. Borghi C, Prandin MG, Costa FV, Bacchelli S, Degli Esposti D, Ambrosioni E. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol 2000; 35: 549–554.
9. Ansell BJ. Cholesterol, stroke risk, and stroke prevention. Curr Atheroscler Rep 2000; 2: 92–96.
10. Lindsey J. Implementing to stroke risk assessment program into community setting. J Neurosci Nurs 2000; 32: 266–270.
11. Rockson SG. Benefits of lipid-lowering agents in stroke and coronary heart disease: Pharmacoeconomics. Curr Atheroscler Rep 2000; 2: 144–150.